The Centers for Disease Control and Prevention confirmed 28 cases of blood clots, three of which resulted in death, associated with Johnson & Johnson’s COVID vaccine, yet officials claim the benefits outweigh the risks.
Officials with the Centers for Disease Control and Prevention (CDC) said Wednesday they see a “plausible causal association” between the Johnson & Johnson COVID vaccine and potentially life-threatening blood clot disorders after identifying 28 cases — including three deaths — among people who received the vaccine.
Dr. Tom Shimabukuro, deputy director of the CDC’s immunization safety office, presented the new cases at a Wednesday meeting of CDC panel advisers, The New York Times reported.
Shimabukuro’s presentation identified 28 cases of thrombosis with thrombocytopenia syndrome (TTS) among people vaccinated with the J&J shot. The cases were based on reports submitted to the CDC’s Vaccine Adverse Events Reporting System, known as VAERS. TTS involves blood clots accompanied by a low level of platelets.
